成人原发免疫性血小板减少症中医诊治专家共识

Traditional Chinese medicine expert consensus on the diagnosis and management of adult primary immune thrombocytopenia

本专家共识就成人原发免疫性血小板减少症的中医病名、主要病机、病机的主要特点和主要临床表现进行了标化和凝练,并就中医和中西医结合治疗本病提出了指导意见。本病分为出血证候和(或)虚损证候,治疗遵循分层次、个体化原则,对血小板计数≥20×10^(9)/L或无明显出血表现者,采用中医药为主治疗;对血小板计数<20×10^(9)/L或存在明显出血表现者,采用中西医结合治疗。不推荐使用大剂量地塞米松或标准剂量泼尼松治疗本病,以避免治疗性伤害。对症治疗能够有效提高患者生活质量,进而有助于提升血小板计数,必须予以充分重视。

This expert consensus has standardized and summarized the traditional Chinese medicine(TCM)disease name,main pathogenesis,main characteristics and main clinical manifestations of adult primary immune thrombocytopenia(ITP),and put forward the guidance of TCM and integrated traditional Chinese and Western medicine treatments of ITP.ITP associates with haematologic syndromes and(or)deficiency syndromes.Treatment should be applied by following stratification and individualization principle.For those patients with platelet count≥20×10^(9)/L or without obvious bleeding manifestations,TCM is the main treatment.The patients with platelet count<20×10^(9)/L or obvious bleeding manifestations could be treated with integrated traditional Chinese and Western medicine.The use of high-dose dexamethasone or standard-dose-prednisone are not recommended for the treatment of ITP to avoid therapeutic injury.Symptomatic treatment can effectively improve patients’life quality,and thus contribute to the increase of platelet count,which must be fully paid attention to.